comparemela.com

Latest Breaking News On - Medical technology company - Page 5 : comparemela.com

Vapotherm (VAPO) Reports Q2 Loss, Misses Revenue Estimates

Vapotherm (VAPO) delivered earnings and revenue surprises of 23.68% and 4.99%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Veru incZacks investment researchZacks consensus estimateZacks medicalZacks rankStrong buyZacks industry rankZacks investmentZacks rankStimate revisionsMedical technology companyPs estimatesOnsensus estimateQuarterly lossConsensus eps estimateArnings estimate

Market Sentiment Around Loss-Making STRATA Skin Sciences, Inc (NASDAQ:SSKN)

STRATA Skin Sciences, Inc. ( NASDAQ:SSKN ) is possibly approaching a major achievement in its business, so we would.

Management teamSkin sciencesSimply wallTrack recordHigh performing stocksMedical technology company

ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of -34.85% and 2.71%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Sight sciences incZacks investment researchZacks consensus estimateZacks medicalZacks rankStrong buyZacks industry rankSight sciencesZacks investmentZacks rankStimate revisionsMedical technology companyOnsensus estimatePs estimatesQuarterly lossConsensus eps estimate

Intelligent Bio Solutions Inc s (NASDAQ:INBS) Profit Outlook

We feel now is a pretty good time to analyse Intelligent Bio Solutions Inc.'s ( NASDAQ:INBS ) business as it appears.

Management teamIntelligent bio solutionsIntelligent bio solutionSimply wallTrack recordHigh performing stocksIntelligent bio solutions incIntelligent bio solutionsIntelligent bioMedical technology companyIndustry analysts

Nemaura Medical Reports Financial Results and Provides

Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company.

United statesUnited kingdomEfaz chowdhuryDrug administrationElectronics incMetabolic healthNemaura medical incNational health service miboko studyRegistered direct offeringPrivate placementNational health serviceMiboko studyBenchmark electronics incNemaura medicalPremarket approval applicationStatement regarding forward looking statements

vimarsana © 2020. All Rights Reserved.